# A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine

> **NCT00253175** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 211 (actual)

## Conditions studied

- Vascular Headaches
- Migraine

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00253175
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** 2001-12
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2010-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00253175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00253175, "A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00253175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*